C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/10 (2006.01) A61K 35/12 (2006.01) A61P 35/00 (2006.01) C12N 15/23 (2006.01) C12N 15/26 (2006.01) C12N 15/867 (2006.01)
Patent
CA 2156273
This invention provides a retroviral vector comprising (a) a 3'LTR; and (b) an insert having (i) a promoter, (ii) a sequence encoding an immunomolecule selected from the group consisting of cytokines, adhesion molecules, costimulatory factors, tumor associated antigens and tumor specific antigens, and (iii) a poly A signal, respectively, said promoter, sequence encoding an immunomolecule and poly A signal being aligned in a 5' to 3' orientation, wherein the insert is positioned within the 3'LTR in the orientation opposite to that of the 3'LTR. This invention further provides a genetically manipulated cell useful for treating or preventing a malignant tumor in a patient which a) expresses at least one immunomolecule selected from the group consisting of cytokines, adhesion molecules, costimulatory factors, tumor associated antigens and tumor specific antigens; and b) is allogenic to the patient.
Gowling Lafleur Henderson Llp
Sloan Kettering Institute For Cancer Research
Sloan-Kettering Institute For Cancer Research
LandOfFree
Allogeneic vaccine and methods to synthesize same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allogeneic vaccine and methods to synthesize same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allogeneic vaccine and methods to synthesize same will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1604905